These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6769666)

  • 41. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician.
    Dutta S; Reed RC
    J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absorption characteristics of EC-MPS--an enteric-coated formulation of mycophenolic sodium.
    Arns W; Gies M; Choi L; Zhu W; Cooper P; Yeh CM; Prasad P; Graf P; Schmouder R
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):375-85. PubMed ID: 16961168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circadian changes of valproate kinetics depending on meal condition in humans.
    Ohdo S; Nakano S; Ogawa N
    J Clin Pharmacol; 1992 Sep; 32(9):822-6. PubMed ID: 1430301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmaceutical evaluation of hollow type suppositories. V. Preparation of valproic acid suppository and rectal absorption of valproic acid in rabbits.
    Watanabe Y; Tone Y; Nishihara S; Matsumoto M
    J Pharmacobiodyn; 1986 Dec; 9(12):953-61. PubMed ID: 3106614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic evaluation of novel sustained-release dosage forms of valproic acid in humans.
    Bialer M; Friedman M; Dubrovsky J; Raz I; Abramsky O
    Biopharm Drug Dispos; 1985; 6(4):401-11. PubMed ID: 3936558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioavailability of a slow-release preparation of valproic acid under steady-state conditions.
    Klotz U
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):24-6. PubMed ID: 6799412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of valproic acid in the elderly.
    Perucca E; Grimaldi R; Gatti G; Pirracchio S; Crema F; Frigo GM
    Br J Clin Pharmacol; 1984 Jun; 17(6):665-9. PubMed ID: 6430313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.
    Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T
    Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of food on the absorption of enteric-coated aspirin: correlation with gastric residence time.
    Mojaverian P; Rocci ML; Conner DP; Abrams WB; Vlasses PH
    Clin Pharmacol Ther; 1987 Jan; 41(1):11-7. PubMed ID: 3802700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium.
    Wang-Smith L; Fort J; Zhang Y; Sostek M
    J Clin Pharmacol; 2012 May; 52(5):670-80. PubMed ID: 21628602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative bioavailability of two enteric-coated tablet preparations of diclofenac sodium.
    Paton DM
    Int J Clin Pharmacol Res; 1987; 7(4):239-42. PubMed ID: 3596865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioavailability of rectally administered valproic acid syrup.
    Cloyd JC; Kriel RL
    Neurology; 1981 Oct; 31(10):1348-52. PubMed ID: 6810203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioavailability of a new controlled-release oral naproxen formulation given with and without food.
    Palazzini E; Cristofori M; Babbini M
    Int J Clin Pharmacol Res; 1992; 12(4):179-84. PubMed ID: 1297641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of valproic acid in volunteers after a single dose study.
    Bialer M; Hussein Z; Raz I; Abramsky O; Herishanu Y; Pachys F
    Biopharm Drug Dispos; 1985; 6(1):33-42. PubMed ID: 3921078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-dose evaluation of a new enteric-coated aspirin preparation.
    Paull P; Day R; Graham G; Champion D
    Med J Aust; 1976 Apr; 1(17):617-9. PubMed ID: 933973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study.
    Islam MS; Trini AB; Shohag H; Ahmed MU; Maruf AA; Hasnat A
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):778-86. PubMed ID: 22122821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of food and tablet formulation on plasma prednisolone levels following administration of enteric-coated tablets.
    Lee DA; Taylor GM; Walker JG; James VH
    Br J Clin Pharmacol; 1979 May; 7(5):523-8. PubMed ID: 475947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of study design in assessing food effects on absorption of erythromycin base and erythromycin stearate.
    DiSanto AR; Chodos DJ
    Antimicrob Agents Chemother; 1981 Aug; 20(2):190-6. PubMed ID: 7283417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of food intake on the bioavailability of sulpiride from AEA film-coated tablet having a pH-dependent dissolution characteristic in normal or drug-induced achlorhydric subjects.
    Shinkuma D; Hamaguchi T; Kobayashi M; Yamanaka Y; Mizuno N
    Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):303-9. PubMed ID: 1743804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.